Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,249,800
+$320,187 QoQ
Shares Held
12,796
+6.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#1,943
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Blueprint, LLC holds $25,782,970 across 8 Drug Manufacturers - General names. JNJ ranks #2 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,696 | $16,427,394 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
12,796 | $3,249,800 | |
| 3 | ABBV |
AbbVie Inc.
|
9,738 | $2,450,470 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,246 | $1,702,111 | |
| 5 | PFE |
Pfizer Inc
|
30,778 | $741,134 | |
| 6 | AMGN |
Amgen Inc
|
1,477 | $534,851 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,819 | $356,152 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,572 | $321,058 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,249,800 | 12,796 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,929,613 | 11,985 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,516,098 | 12,158 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,610,899 | 14,081 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,093,897 | 13,708 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,701,036 | 16,287 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,373,214 | 16,410 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,656,811 | 16,394 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,634,241 | 18,023 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,941,543 | 18,595 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,838,561 | 18,110 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,911,902 | 18,696 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $3,160,769 | 19,096 | Shares | Sole | 2023-10-18 | |
| 2023-03-31 | $2,878,970 | 18,574 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $3,191,182 | 18,065 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $2,808,811 | 17,194 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,767,203 | 15,589 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,546,972 | 14,371 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $2,278,139 | 13,317 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,883,090 | 11,660 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,729,440 | 10,498 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,515,307 | 9,220 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,306,096 | 8,299 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,164,241 | 7,820 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $878,796 | 6,249 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $883,422 | 6,737 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||